arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Alphatec Holdings, Inc.

ATEC
$7.78 ▼ -0.51 (-6.15%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
69 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alphatec Holdings, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B
Dividend Yield —
Revenue Growth 12.6% ↘
Op. Margin 1.5% ↗
ROIC 0.8% ↗
FCF / Share $0.04 ↗
Trailing P/E —
Price / Book —
FCF Yield 0.5%
Debt / Equity -239.92
info Valuation on last close. End-of-day price, Nov 5, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$221.17M
↑ +12.6% —
Net Income Profit after all expenses
$-33.91M
↑ +34.7% —
Operating Margin Operating profit as % of sales
1.5%
↑ +264.2% 14th
FCF / Share Free cash flow per share
$0.04
↑ +851.5% —
Long-Term Debt Long-term obligations
$547.00M
↓ -5.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
17
Financial Health ↑
22
Cash Quality
21

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters